Spectrum of pathogens in acute cholangitis in patients with and without biliary endoprosthesis.

Link to article at PubMed

Related Articles

Spectrum of pathogens in acute cholangitis in patients with and without biliary endoprosthesis.

J Infect. 2013 Apr 17;

Authors: Weber A, Schneider J, Wagenpfeil S, Winkle P, Riedel J, Wantia N, Feihl S, Römmler F, Baur DM, Schmid RM, Algül H, Huber W

Abstract
SUMMARY BACKGROUND: Knowledge of bacterial spectrum for acute cholangitis is essential for adequate empiric antibiotic treatment. Main focus of the study was to analyse the spectrum of pathogens in acute cholangitis with and without biliary endoprosthesis. METHODS: Retrospective cohort study of 1024 patients with acute cholangitis treated at a German tertiary center. RESULTS: 447 cholangitis episodes with positive bile and/or blood cultures obtained from 388 patients were studied. In total, 1088 pathogen were isolated. The predominant strains were Enterococcus species (25%), followed by Escherichia coli (18%) and Klebsiella species (14%). Bacteraemia was mainly caused by Escherichia coli (91/282; 32%) and Enterococcus species (52/282; 18%). The incidences of Enterococcus species [121(74%) vs. 89(60%); p= 0.011] and non-fermenters [41(25%) vs. 16(11%); p= 0.001] were significantly higher in cholangitis episodes with biliary endoprosthesis compared to cholangitis episodes without biliary endoprosthesis. In particular, more Pseudomonas aeruginosa [27(16%) vs. 12(8%); p= 0.027] and Enterococcus faecium [59(36%) vs. 34(23%); p= 0.013] were isolated from patients with a biliary endoprosthesis. CONCLUSIONS: Unlike cholangitis without stent, the presence of biliary endoprosthesis in patients with cholangitis can serve as a surrogate indicator of nosocomial pathogens and therefore should be considered, when selecting empiric antimicrobial therapy.

PMID: 23603487 [PubMed - as supplied by publisher]

Leave a Reply

Your email address will not be published. Required fields are marked *